Dr. Ebrahimi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1910 Royalty Dr
Pomona, CA 91767Phone+1 909-630-7342Fax+1 909-630-7380
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2000 - 2003
- Baylor College of MedicineResidency, Internal Medicine, 1997 - 2000
- Baylor College of MedicineClass of 1997
Certifications & Licensure
- CA State Medical License 2002 - 2026
- TX State Medical License 1998 - 2005
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013
Publications & Presentations
PubMed
- 237 citationsCytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis.Behnam Ebrahimi, Susan L. Tucker, Donghui Li, James L. Abbruzzese, Razelle Kurzrock
Cancer. 2004-12-15 - 37 citationsPhase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer.Yuan Yuan, Jin Sun Lee, Susan E. Yost, Paul Frankel, Christopher Ruel
European Journal of Cancer. 2021-07-01 - 6 citationsA First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer.Kristin A Altwegg, Suryavathi Viswanadhapalli, Monica Mann, Dimple Chakravarty, Samaya Krishnan
Cancer Research. 2022-10-17
Press Mentions
- CliniCians Southern CaliforniaSeptember 28th, 1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: